AI Regulatory
Compliance for Life Sciences and Insurance Model Governance

Regulated life sciences and insurance organizations are deploying machine learning in research, clinical AI development, risk scoring, and claims workflows. Governance often lags, and the lag shows up as slow approvals, inconsistent documentation, and elevated audit risk.

This case study summarizes how i-GENTIC AI supported teams spanning pharmaceutical research and clinical AI development, as well as insurance analytics groups focused on predictive risk and claims decisioning. Stakeholders included data science leadership, regulatory affairs, ethics committee representatives, and executive sponsors responsible for enterprise risk.

The challenge: manual governance created bottlenecks and uneven evidence

Teams were spending significant time documenting how models were built, validated, approved, and monitored. In this engagement, compliance work consumed an estimated 5,200 hours per year, largely driven by repetitive evidence gathering and back-and-forth between data science and review functions.

Documentation quality was inconsistent. Approximately 38% of models were missing key audit details such as lineage, retraining history, validation artifacts, or a defensible rationale for risk classification. For higher-risk use cases, including models influencing claims processing decisions, governance reviews also surfaced bias concerns that created additional regulatory and reputational exposure. The regulatory landscape added complexity, with requirements and standards including the EU AI Act, emerging algorithmic accountability expectations, ISO 23053, and 21 CFR Part 11 where controlled records and electronic signatures applied.

The solution: GENIE™ operationalized documentation, risk classification, and reporting

i-GENTIC AI deployed GENIE™, an agentic AI governance solution that executed core governance workflows that had been handled manually:

-Documentation audits to check for required evidence (explainability artifacts, lineage, training and retraining details, validation evidence, change history) and flag gaps as actionable findings.
-Risk classification and escalation to apply consistent treatment to high-risk contexts, including claims-related and other decisioning models.
-Compliance reporting and evidence generation to produce draft reports for stakeholders, route outputs for approvals, and maintain an auditable record.

A key element was standardizing model card templates and having GENIE™ populate known deployment details, then orchestrate required remediation steps and sign-offs when gaps or risks were identified.

Outcomes: faster approvals, stronger audit posture, lower incident risk

Automating the governance lifecycle reduced manual work and improved consistency across reviews.

-Faster approvals (67%) driven by earlier, more consistent evidence capture and fewer review cycles.
-Zero regulatory violations in the latest AI governance audits due to defined remediation workflows and complete documentation coverage.
-100% audit trails for governed models, including review actions and approvals.
-Reduced financial exposure with an estimated $1.2M average savings per regulatory exposure, reflecting avoided compliance incidents and remediation disruption.

If your life sciences or insurance organization is deploying machine learning models and governance still depends on spreadsheets, email, and inconsistent model cards, i-GENTIC AI can map your current workflow and show where GENIE™ can automate documentation, classification, and compliance reporting.

Contact us today for a demo